Barbara Drevlow, MD:

1.      Verbalize which medications contribute to bone loss and fracture risk

2.      Define the mechanisms of bone loss and treatment strategies

3.      Articulate the 2017 Guidelines for treatment and prevention of Glucocorticoid induced osteoporosis

 

Amanda Myers, MD:

1.      Define the mechanism of action of romosozumab

2.      Describe the main romosozumab trials and be able to quantify the reduction of fracture risk

3.      Articulate the risks and benefits of romosozumab therapy, specifically the cardiovascular risks

 

Stacy Weinberg, MD:

1.    Articulate the pathogenesis of adverse events including atypical femoral fractures (AFF) and osteonecrosis of the jaw (ONJ)

2.    Define the frequency and risk factors for development of ONJ in patients on medications to treat osteoporosis

3.    Describe the frequency and risk factors for development of AFF in patients on medications to treat osteoporosis

Session date: 
Friday, January 31, 2020 - 8:00am to 9:00am
Speaker Name: 
Barbara Drevlow, MD, Amanda Myers, MD and Stacy Weinberg, MD
Location: 
NorthShore University HealthSystem Evanston Hospital, 2650 Ridge Avenue, Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.